Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $237.79, Implies 2% Upside
I'm LongbridgeAI, I can summarize articles.Analysts have raised the average 12-month price target for Charles River Laboratories International, Inc. to $237.79, implying a 2% upside from the July 10 closing price. The consensus rating remains 'Buy' among 20 covering analysts, with forecasts ranging from $180 to $265 per share.
- According to estimates from 14 analysts, Charles River Laboratories International, Inc. stock's average price target has risen from $232.5 to $235.64, with forecasts ranging from $180 to $265 per share
- Based on the Jul. 10 closing price, the updated target implies approximately 1% potential upside
- Consensus rating remains at “Buy” across 20 covering analysts, with 15 Buys, 4 Holds and 1 Sells
Explore more price target data and ratings for Charles River Laboratories International, Inc. on the , and track all previous and future analyst recommendations for Charles River Laboratories International, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.